Compare Kothari Ferment. with Similar Stocks
Dashboard
Weak Long Term Fundamental Strength with a -32.96% CAGR growth in Operating Profits over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 5.49 times
- The company has been able to generate a Return on Equity (avg) of 1.98% signifying low profitability per unit of shareholders funds
Flat results in Dec 25
Below par performance in long term as well as near term
Total Returns (Price + Dividend) 
Kothari Ferment. for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Kothari Fermentation & Biochem Ltd is Rated Strong Sell
Kothari Fermentation & Biochem Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 14 July 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 05 March 2026, providing investors with the most recent insights into the stock’s performance and outlook.
Read full news article
Kothari Fermentation & Biochem Ltd Stock Hits 52-Week Low Amidst Continued Downtrend
Kothari Fermentation & Biochem Ltd’s shares declined sharply to a new 52-week low of Rs.36 on 2 Mar 2026, marking a significant downturn amid a series of consecutive losses. The stock has underperformed its sector and broader market indices, reflecting ongoing concerns about the company’s financial health and long-term growth prospects.
Read full news article
Kothari Fermentation & Biochem Ltd Falls to 52-Week Low of Rs.37.15
Kothari Fermentation & Biochem Ltd’s stock declined sharply to a fresh 52-week low of Rs.37.15 on 27 Feb 2026, marking a significant downturn amid sustained underperformance relative to its sector and benchmark indices.
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
14-Feb-2026 | Source : BSENewspaper publication w.r.t Unaudited Financial Results for the quarter and nine months ended 31/12/2025.
Financial Results For The Quarter And Nine Months Ended On 31/12/2025
13-Feb-2026 | Source : BSEPlease refer to the attached annexure.
Board Meeting Outcome for Outcome Of Board Meeting Held On February 13 2026 W.R.T Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended On December 31 2025
13-Feb-2026 | Source : BSEPlease refer to the attached annexure.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Siddhant Kothari (24.85%)
Dheeraj Kumar Lohia (1.36%)
27.52%
Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is 33.35% vs 0.88% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is 87.66% vs -175.00% in Sep 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -7.40% vs 6.64% in Sep 2024
Growth in half year ended Sep 2025 is -546.15% vs 89.45% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is -2.91% vs 6.71% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -1,808.33% vs 95.85% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is 4.91% vs -1.26% in Mar 2024
YoY Growth in year ended Mar 2025 is 116.50% vs -2,684.21% in Mar 2024






